Boston Scientific Recalls Accolade Pacemaker Devices
Pacemakers recalled due to manufacturing issue that may lead to early device replacement
AI-Assisted Screening Tool Speeds Trial Eligibility Determination
Implementing AI-assisted screening tool enhances clinical trial efficiency, expedites screening process
Diabetes, Dyslipidemia Screening Rates Low After Pregnancy, Even for Those With HTN, GDM
Although screening rates are higher for exposed individuals, rates are low in both exposed and unexposed individuals
Systolic BP Target <120 mm Hg Favored for Most Participants in BP Intervention Trial
Almost all older adults in SPRINT trial have predicted net benefit favoring systolic BP target <120 mm Hg versus <140 mm Hg
Sisters of Those With Adverse Pregnancy Outcome Also Have Increased CVD Risk
Women with APO and their APO-free sisters both have increased risks relative to unrelated APO-free comparators
Olpasiran Leads to Significant Reduction in Oxidized Phospholipids
Olpasiran leads to significant and sustained reduction in OxPL on apolipoprotein B
Certain Glucose-Lowering Meds Associated With Lower Risk for COPD Exacerbations
Lower risk for COPD exacerbations seen with SGLT-2 inhibitors and GLP-1 receptor agonists, but not with DPP-4 inhibitors
Recent Decade Saw Rise in Number of Adults With Severe Obesity
Additionally, small increases seen in the percentage of children and adolescents with obesity
Inconsistent Link Seen Between Wildfires and CVD Events, Mortality
Increased rate of CVD events and death seen with high level of fine particulate matter during Mendocino Complex wildfire
De-Escalating DAPT to Ticagrelor Monotherapy Cuts Bleeding Risk in Acute Coronary Syndrome
Lower risk for bleeding without increase in ischemic events seen for patients with acute coronary syndrome
